Clinical Trials
10
Trial Phases
3 Phases
Drug Approvals
7
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Eight Week Study of Treatment With DFD-07 for Actinic Keratosis of the Face and Scalp
- Conditions
- Actinic Keratosis
- Interventions
- Drug: DFD-07 CreamDrug: Placebo Cream
- First Posted Date
- 2016-01-13
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Promius Pharma, LLC
- Target Recruit Count
- 111
- Registration Number
- NCT02654717
- Locations
- 🇩🇪
Site One, Bochum, Germany
🇩🇪Site Two, Bonn, Germany
🇩🇪Site Three, Wuppertal, Germany
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis
- Conditions
- Psoriasis
- Interventions
- Drug: DFD06 CreamDrug: Vehicle Cream
- First Posted Date
- 2015-12-18
- Last Posted Date
- 2018-05-15
- Lead Sponsor
- Promius Pharma, LLC
- Target Recruit Count
- 267
- Registration Number
- NCT02635204
- Locations
- 🇺🇸
Site 116, Glendale, Arizona, United States
🇺🇸Site 111, Rogers, Arkansas, United States
🇺🇸Site 124, Fountain Valley, California, United States
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis
- Conditions
- Chronic Stable Plaque Psoriasis
- Interventions
- Drug: DFD06-CreamDrug: Vehicle Cream
- First Posted Date
- 2015-05-15
- Last Posted Date
- 2018-05-15
- Lead Sponsor
- Promius Pharma, LLC
- Target Recruit Count
- 265
- Registration Number
- NCT02445807
- Locations
- 🇺🇸
Site 101, Birmingham, Alabama, United States
🇺🇸Site 103, Mobile, Alabama, United States
🇺🇸Site 130, Mesa, Arizona, United States
DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis
- Conditions
- Psoriasis
- Interventions
- Drug: DFD06 Cream
- First Posted Date
- 2014-05-06
- Last Posted Date
- 2018-05-18
- Lead Sponsor
- Promius Pharma, LLC
- Target Recruit Count
- 50
- Registration Number
- NCT02131324
- Locations
- 🇺🇸
Advanced Research Associates, Glendale, Arizona, United States
🇺🇸Agave Clinical Research, LLC, Mesa, Arizona, United States
🇺🇸T. Joseph Raoof, MD, Inc., Encino, California, United States
ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis
- Conditions
- Actinic Keratosis
- Interventions
- First Posted Date
- 2014-04-30
- Last Posted Date
- 2016-02-22
- Lead Sponsor
- Promius Pharma, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT02126670
- Locations
- 🇺🇸
Therapeutics Clinical Research, San Diego, California, United States
🇺🇸Dermatology Specialists Research, LLC, Louisville, Kentucky, United States
🇺🇸Dermatology Consulting Services; Zoe Diana Draelos, MD, High Point, North Carolina, United States
- Prev
- 1
- 2
- Next